PROVIDER PROFILE · NPI 1689690406

Mark TalamontiMD

Surgical OncologyEvanston, ILI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

123

Unique beneficiaries

—

Total services

144

Distinct HCPCS

Medicare payment

$6K

Peer benchmark

Total Medicare services vs. 51 Surgical Oncology providers in IL — below median (cohort median 256).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$243K

Distinct drugs

Brand share

77.2%

Top prescribed drugs

Lipase/Protease/Amylase61 claims

Pantoprazole Sodium18 claims

QUALITY · MIPS · 2024

Final MIPS score

84.9

Quality

75.9

Cost

74.6

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

0.42%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$215

Payment records

By payment type

Food and Beverage$215

REFERRAL NETWORK

Where Mark Talamonti's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ENDEAVOR HEALTH CLINICAL OPERATIONS	140	812
Robert Marsh Medical Oncology · Evanston, IL	29	90
Geraldine Newmark Diagnostic Radiology · Evanston, IL	21	49
Daniel Wenzke Diagnostic Radiology · Evanston, IL	16	42
Hector Ferral Diagnostic Radiology · Evanston, IL	13	65
Carolyn Donaldson Diagnostic Radiology · Evanston, IL	13	28
Marc Alonzo Interventional Radiology · Evanston, IL	12	54

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history